Copied
 
 
2022, EUR
19.04.2023
Bruttoresultat

168'

Primær drift

34.553

Årets resultat

26.671

Aktiver

206'

Kortfristede aktiver

206'

Egenkapital

176'

Afkastningsgrad

17 %

Soliditetsgrad

85 %

Likviditetsgrad

0 %

Resultat
19.04.2023
Årsrapport
2022
19.04.2023
2021
24.06.2022
2020
19.03.2021
2019
11.03.2020
2018
12.04.2019
2017
03.04.2018
2016
02.05.2017
2015
03.05.2016
Nettoomsætning
Bruttoresultat167.667144.439129.57759.92365.80485.45161.8850
Resultat af primær drift34.55341.73060.031-3.9002.74226.743-2.198174.580
Indtægter af kapitalandele (tilknyttede og associerede) 00000000
Finansielle indtægter01161150071743.783
Finansieringsomkostninger00000001.170
Andre finansielle omkostninger0-635000-178-1900
Resultat før skat34.55341.21160.146-3.9182.35626.572-2.214177.193
Resultat26.67131.62146.414-3.0641.68621.065-2.129129.553
Forslag til udbytte00-33.60500000
Aktiver
19.04.2023
Årsrapport
2022
19.04.2023
2021
24.06.2022
2020
19.03.2021
2019
11.03.2020
2018
12.04.2019
2017
03.04.2018
2016
02.05.2017
2015
03.05.2016
Kortfristede varebeholdninger00000000
Kortfristede tilgodehavender fra salg og tjenesteydelser 62.61171.454101.10049.76420.55714.33610.639254.993
Likvider143.270133.06294.13977.024106.287106.80683.994535.179
Kortfristede aktiver205.881204.516195.239126.788126.844121.14294.6330
Immaterielle aktiver og goodwill00000000
Finansielle anlægsaktiver00000000
Materielle aktiver00000000
Langfristede aktiver0000003415.915
Aktiver205.881204.516195.239126.788126.844121.14294.974796.087
Aktiver
19.04.2023
Passiver
19.04.2023
Årsrapport
2022
19.04.2023
2021
24.06.2022
2020
19.03.2021
2019
11.03.2020
2018
12.04.2019
2017
03.04.2018
2016
02.05.2017
2015
03.05.2016
Forslag til udbytte0033.60500000
Egenkapital175.750149.079151.063104.649107.713106.02784.962647.467
Hensatte forpligtelser00000001.301
Langfristet gæld til banker00000000
Anden langfristet gæld00000000
Leverandører af varer og tjenesteydelser00000000
Kortfristede forpligtelser00000000
Gældsforpligtelser0000000147.319
Forpligtelser0000000147.319
Passiver205.881204.516195.239126.788126.844121.14294.974796.087
Passiver
19.04.2023
Nøgletal
19.04.2023
Årsrapport
2022
19.04.2023
2021
24.06.2022
2020
19.03.2021
2019
11.03.2020
2018
12.04.2019
2017
03.04.2018
2016
02.05.2017
2015
03.05.2016
Afkastningsgrad 16,8 %20,4 %30,7 %-3,1 %2,2 %22,1 %-2,3 %21,9 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 15,2 %21,2 %30,7 %-2,9 %1,6 %19,9 %-2,5 %20,0 %
Payout-ratio Na.Na.72,4 %Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal Na.Na.Na.Na.Na.Na.Na.-14.921,4 %
Soliditestgrad 85,4 %72,9 %77,4 %82,5 %84,9 %87,5 %89,5 %81,3 %
Likviditetsgrad Na.Na.Na.Na.Na.Na.Na.Na.
Resultat
19.04.2023
Gæld
19.04.2023
Årsrapport
19.04.2023
Nyeste:01.01.2022- 31.12.2022(offentliggjort: 19.04.2023)
Beretning
19.04.2023
Dato for ledelsens godkendelse af årsrapporten:2023-03-29
Ledelsespåtegning:Management's statement
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The Board of Directors and the management have today presented the Annual Report of Modiform Nordic A/S for 2022.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Substantial activities of the companyThe company earns its revenue from marketing the products of the parent company and related products from other vendors in the Scandinavian market. Development in 2022During January 2021 to June 2022, Modiform B. V. had a very good time. Covid-19 has had a positive impact on Modiform's business. People were not allowed to go on holidays, leading to people spending money to furnish their gardens with beautiful plants. From July 2022 to date, Modiform B. V.'s business has been slightly down. A combination of war in Ukraine resulting in rising cost of energy, rising inflation and the end of Covid-19. Flowers are a luxury product, in case of rising inflation, this will reduce the demand for flowers. We remain confident that our products will be sold, perhaps less than in recent years. But even with lower sales, Modiform can achieve positive results.